$Oscar Health, Inc.(OSCR)$ $Centene(CNC)$ $UnitedHealth(UNH)$ 📈🐳 $OSCR Ignition: Whale Sweep + ACA Extension Signal Re-Rating Toward $30 🚀
JD Vance dropped a policy bomb this morning: “I’m open to discussing ACA premium support with Schumer and Senate Democrats, but only once the government is reopened.” That line is a signal flare. It confirms exactly what I’ve been pointing out: an extension is coming. The ACA backdrop matters because it strengthens the revenue runway for insurers like Oscar Health, and the market knows it.
🐳 Whale activity backs it up. A $93K sweep just hit the $21C expiring 31OCT2025, stacking call volume far above open interest. That’s not noise. That’s conviction positioning for a policy-driven upside.
📊 Technicals show the story lining up. On the daily, $OSCR is moving cleanly through support-resistance pivots.
🔵 Support (Floor / Stability): $18.34 as the first key floor, $17.31 as secondary, and $16.28 as stronger base.
🔴 Resistance (Stop / Danger Zone): $19.82 as the immediate supply zone, $21.61 as the decisive resistance, and $22.95 as the peak ceiling.
🟠 Breakout Alerts (Ignition): Clearing $19.82 with volume is the spark, above $20 is psychological confirmation, and above $21.61 is expansion with shorts trapped.
🟢 Upside Targets (Profit / Go): Short-term $21.61, mid-term $22.95, long-term $26–$30 if margins improve and ACA tailwinds confirm.
📊 Probability-weighted roadmap:
Bull Case (55%): Holds $18.34, clears $20–$21.61, whale flow aligns with policy momentum, guidance raised FY26–27 (+15% rev/EPS), re-rating to $26–30.
Base Case (30%): Ranges $18.34–$19.82, volatility compresses awaiting ACA clarity, consolidation sets up delayed breakout.
Bear Case (15%): Breaks $18.34 and $17.31, policy talks stall, margins fail to improve, retest $16.28–$15, with risk to $13.90–$13.11 if macro unwinds.
🔎 Fundamentals remain a high-beta lever. With FY26–FY27 guidance likely to get raised 15%+ in Revenue and EPS on policy tailwinds, the valuation math can reset quickly. Float is only 3.97B, and with 16M shares traded yesterday, you’re seeing meaningful churn. I like the setup here. Margins improving could be the final catalyst that lets $OSCR double over the next 9–12 months. But near-term, it’s all about clearing $20 cleanly.
👉❓Does this whale flow signal a stealth accumulation phase before ACA policy headlines ignite a $20+ breakout?
📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀
Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
@Tiger_comments @TigerStars @TigerObserver @TigerPM
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Cool Cat Winston·10-03TOP📊 I like how you laid out the roadmap here. That $19.82 level on $OSCR feels like the exact same kind of wall we saw on $CNC earlier this year. If it clears with conviction volume, the re-rating story you mapped really kicks in.3Report
- Hen Solo·10-03TOP🐋 The options flow is wild. $93K on the $21C is no retail punt. It’s exactly what we saw with $HIMS before its move. If margins hold, that bull case toward $30 feels realistic with the ACA tailwinds in play.3Report
- Tui Jude·10-03TOP🩺 What stands out to me is the ACA policy alignment. $UNH is always the benchmark but the whale sweep at the $21C makes Oscar look like the higher torque play. Clearing $20 lines up well with the institutional flows you mentioned.3Report
- Kiwi Tigress·10-03TOPThe whale sweep callout really hits. $OSCR moving with that kind of ACA momentum feels like a setup that’s bigger than just one earnings cycle. Those upside targets you mapped are legit acceleration levels if we get the $20+ close2Report
- Queengirlypops·10-03TOPthat $21C flow is screaming smart money. The way you tied ACA extension to a clean breakout map is fire. If it clears $20 with volume this chart gonna move quick into that $22 zone. Feels like one of those re-rate plays you don’t wanna fade 🧃1Report
- Jo Betsy·10-03Analysts target $11—will whale flow override their bearish calls?1Report
- Mortimer Arthur·10-05Loaded up on OSCR at 18.00 and CRMD 11.20 low PE and +ebita technically both look great massive growth.LikeReport
- Merle Ted·10-05Oscar Health and CRMD low PE + EBITA money making machines both should be trading multiples higherLikeReport
- Ron Anne·10-03CNC’s safer, but OSCR’s ACA leverage makes it way more explosive.1Report
- Wade Shaw·10-0315% bear case—what if Q3 margins don’t match Q1’s strength?LikeReport